Bifogade filer
PDF
Kurs
+3,20%
Likviditet
4,76 MSEK
Kalender
| Est. tid* | ||
| 2026-02-06 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-24 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-07 | - | X-dag ordinarie utdelning HUM 1.00 SEK |
| 2025-05-06 | - | Årsstämma |
| 2025-04-24 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-06 | - | Bokslutskommuniké 2024 |
| 2024-10-23 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-19 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-08 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2024-05-07 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-08 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-21 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2023-05-09 | - | Årsstämma |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-09 | - | Bokslutskommuniké 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2022-05-10 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-10 | - | Bokslutskommuniké 2021 |
| 2021-11-11 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2021-05-11 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-08 | - | X-dag ordinarie utdelning HUM 0.00 SEK |
| 2020-05-07 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-05-10 | - | X-dag ordinarie utdelning HUM 0.70 SEK |
| 2019-05-09 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-16 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | X-dag ordinarie utdelning HUM 0.60 SEK |
| 2018-05-16 | - | Årsstämma |
| 2018-05-16 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-21 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-18 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-19 | - | X-dag ordinarie utdelning HUM 0.50 SEK |
| 2017-05-18 | - | Årsstämma |
| 2017-05-18 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-18 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-19 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
The Swedish investment company Impilo becomes new large shareholder in Humana following the acquisition of a large ownership stake in the Nordic care company.
Humana has been informed that Impilo, a Nordic based investment company focusing on the care and healthcare sector in the Nordic region, has reached an agreement to acquire circa 12.5% of the votes and capital in Humana from Humana's largest shareholder Argan Capital, making Impilo the second largest shareholder in Humana, after Argan Capital. Through the transaction Argan Capital reduces its shareholdings in Humana from circa 39.2% to circa 26.7%.
- I'm very pleased to welcome Impilo as a new shareholder in Humana. The Impilo team has an expressed long term perspective in its investments and I look forward to working together and taking part of their experiences and knowledge of the industry, Rasmus Nerman, President and CEO, said.
- The care sector is central in creating a functioning welfare system in the Nordic region. Thanks to our exclusive focus on the healthcare sector and experience from developing growing companies, we believe we can support Humana over the long term in developing and establishing an even stronger platform for delivering these services with high quality and efficiency, Fredrik Strömholm, Partner at Impilo, said.
- After more than ten years as the principal shareholder of Humana Argan Capital is pleased to welcome Impilo as a new large shareholder in the company. We are confident that Impilo will play an important role in supporting Humana through its next stage of development, Lloyd Perry, a Managing Partner at Argan Capital, said.
Argan Capital became the majority shareholder in Humana in 2008 and has supported the business through a more than six-fold increase in revenues over the past ten years.
Read more:
About Impilo, visit www.impilo.se
About Argan Capital, visit www.argancapital.com
For more information, please contact:
Rasmus Nerman, President and CEO, +46 70 828 18 60, rasmus.nerman@humana.se
Anna Sönne, Head of Investor Relations, +46 70 601 48 53, anna.sonne@humana.se
Fredrik Strömholm, Partner Impilo, + 46 76 115 10 65, fredrik.stromholm@impilo.se
Lloyd Perry, Managing Partner Argan Capital, lperry@argancapital.com